Michelle Baker - Regis Healthcare New Queensland
| REG Stock | 6.56 0.08 1.23% |
Executive
Michelle Baker is New Queensland of Regis Healthcare
| Address | 293 Camberwell Road, Camberwell, VIC, Australia, 3124 |
| Phone | 61 3 8573 0444 |
| Web | https://www.regis.com.au |
Regis Healthcare Management Efficiency
The company has return on total asset (ROA) of (0.012) % which means that it has lost $0.012 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.7616) %, meaning that it generated substantial loss on money invested by shareholders. Regis Healthcare's management efficiency ratios could be used to measure how well Regis Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. Non Current Liabilities Other is likely to gain to about 5 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 1.2 B in 2024.Similar Executives
| Found 4 records | EXECUTIVE Age | ||
| Bus FCIS | Staude Capital Global | 59 | |
| Chris Stott | Wam Leaders | N/A | |
| AO BSc | Wam Leaders | 65 | |
| Matthew Haupt | Wam Leaders | N/A | |
Management Performance
| Return On Equity | -2.76 | ||||
| Return On Asset | -0.012 |
Regis Healthcare Leadership Team
Elected by the shareholders, the Regis Healthcare's board of directors comprises two types of representatives: Regis Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Regis. The board's role is to monitor Regis Healthcare's management team and ensure that shareholders' interests are well served. Regis Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Regis Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Carolyn Noumertzis, Chief Officer | ||
| Bryan Dorman, CoFounder Director | ||
| Rick FCA, Chief Officer | ||
| Imtiaz Bhayat, Chief Officer | ||
| BSc BA, MD CEO | ||
| Michael Horwood, Gen Property | ||
| AGIA BBus, G Sec | ||
| Jodie Haydon, Chief Officer | ||
| Phillip Mackney, South Victoria | ||
| Michelle Baker, New Queensland |
Regis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Regis Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.76 | ||||
| Return On Asset | -0.012 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 1.89 B | ||||
| Shares Outstanding | 301.25 M | ||||
| Shares Owned By Insiders | 51.13 % | ||||
| Shares Owned By Institutions | 11.76 % | ||||
| Price To Book | 259.34 X | ||||
| Price To Sales | 2.02 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Regis Stock Analysis
When running Regis Healthcare's price analysis, check to measure Regis Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regis Healthcare is operating at the current time. Most of Regis Healthcare's value examination focuses on studying past and present price action to predict the probability of Regis Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regis Healthcare's price. Additionally, you may evaluate how the addition of Regis Healthcare to your portfolios can decrease your overall portfolio volatility.